TTK Healthcare paid a penalty of ₹9,93,320 to the Customs Department on June 01, 2026, to resolve a dispute regarding the classification of imported products. The payment was made suo motto by the company to close the matter after the department insisted on a penalty equivalent to 15% of the differential duty paid.

The company had been importing various products under Classification 90191010, covering mechanotherapy appliances, which attracted a basic customs duty of 7.5%. Subsequently, the Customs Department indicated that the classification should be under 90191020 for massage apparatus, which carries a basic customs duty of 10%. Upon receiving this information, the company paid the arrears of the differential duty of 2.5% along with the applicable interest.

The filing clarified that there was no suppression of information, and the issue pertained solely to the change in product classification as indicated by the authorities. Despite the payment of arrears, the Customs Department insisted on the penalty. Consequently, the company decided to pay the amount to settle the matter.

The disclosure was made to the exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The payment was confirmed by Gowry A Jaishankar, DGM – Legal & Company Secretary and Compliance Officer.

T T Lakshman, a promoter shareholder of TTK Healthcare Limited, has submitted a formal declaration confirming that no encumbrance was created on his shareholding in the company during the financial year 2025-26. The declaration, dated April 01, 2026, was filed in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Declaration Details

The filing was addressed to BSE Limited, National Stock Exchange of India Limited, and the Audit Committee of TTK Healthcare Limited. T T Lakshman confirmed that neither directly nor indirectly did he create any encumbrance on his equity shareholding during the relevant financial year. The key details of the declaration are summarised below:

Regulatory Compliance

The declaration was filed in accordance with SEBI's Takeover Regulations, which require promoters and persons acting in concert to disclose any encumbrance created, invoked, or released on shares held in a listed company. T T Lakshman's submission confirms full compliance with this regulatory requirement for the financial year 2025-26, with no encumbrance reported on the 2,67,195 equity shares of Rs. 10/- each held in TTK Healthcare Limited.